Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1963641rdf:typepubmed:Citationlld:pubmed
pubmed-article:1963641lifeskim:mentionsumls-concept:C0027934lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:1963641lifeskim:mentionsumls-concept:C1707723lld:lifeskim
pubmed-article:1963641pubmed:issue3lld:pubmed
pubmed-article:1963641pubmed:dateCreated1991-4-15lld:pubmed
pubmed-article:1963641pubmed:abstractText1. With the aim of gaining insight into the mechanism of Ca2(+)-dependent secretion, inhibition of transmitter release by botulinum neurotoxins or their fragments was studied at mammalian motor nerve terminals, cerebrocortical synaptosomes and PC-12 cells. 2. Relative to BoNT type A, the feeble neuromuscular paralytic activity of its two chains and the lack of activity observed with a proteolytic fragment, H2L (lacking H1, the C-terminal half of the heavy chain) highlight a requirement of the intact, disulphide-linked dichain protein for efficient targetting (binding/uptake) to peripheral cholinergic nerve endings. 3. In PC-12 cells, the renatured light chain alone proved equally potent as the whole toxin in reducing Ca2(+)-evoked noradrenaline release, when digitonin-permeabilization was used to overcome the uptake barrier. Treatment of BoNT A with 10 mM dithiothreitol, under non-denaturing conditions, was not very effective in reducing its inter-chain disulphide bond(s) and had little influence on the level of inhibition seen. 4. Altering the intra-synaptosomal concentrations of cyclic nucleotides (c-AMP, c-GMP) or protein kinase C activity failed to affect the reduction of Ca2(+)-dependent K(+)-stimulated noradrenaline release caused by BoNT A or B. On the other hand, raising the cytosolic Ca2+ concentration with the ionophore A23187 reversed the inhibitory effect of BoNT A to a greater extent than that of type B, revealing differences in their actions. 5. Whereas BoNT-induced decrease of Ca2(+)-dependent K(+)-evoked release of noradrenaline was unaffected by destruction of the actin-based cytoskeleton in synaptosomes with cytochalasin D, disassembly of microtubules with colchicine, nocodazole or griseofulvin antagonised the intracellular action of type B but not A. It is speculated that BoNT B blocks transmitter release by interfering with the proposed detachment of synaptic vesicles from microtubules. Establishing the precise involvement of tubulin in the toxin's action may provide a valuable clue to the mechanism of neurotransmitter release or its control.lld:pubmed
pubmed-article:1963641pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1963641pubmed:languageenglld:pubmed
pubmed-article:1963641pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1963641pubmed:citationSubsetIMlld:pubmed
pubmed-article:1963641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1963641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1963641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1963641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1963641pubmed:statusMEDLINElld:pubmed
pubmed-article:1963641pubmed:issn0021-7948lld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:TaucLLlld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:DollyJ OJOlld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:MellingJJlld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:ShortA JAJlld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:PoulainBBlld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:McInnesCClld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:WadsworthJ...lld:pubmed
pubmed-article:1963641pubmed:authorpubmed-author:AshtonA CAClld:pubmed
pubmed-article:1963641pubmed:issnTypePrintlld:pubmed
pubmed-article:1963641pubmed:volume84lld:pubmed
pubmed-article:1963641pubmed:ownerNLMlld:pubmed
pubmed-article:1963641pubmed:authorsCompleteYlld:pubmed
pubmed-article:1963641pubmed:pagination237-46lld:pubmed
pubmed-article:1963641pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:meshHeadingpubmed-meshheading:1963641-...lld:pubmed
pubmed-article:1963641pubmed:year1990lld:pubmed
pubmed-article:1963641pubmed:articleTitleClues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.lld:pubmed
pubmed-article:1963641pubmed:affiliationDepartment of Biochemistry, Imperial College, London, U.K.lld:pubmed
pubmed-article:1963641pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1963641pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:1963641pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed